SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

SILVA, Maria Elizabeth Rossi da; MORY, Denise  and  DAVINI, Elaine. Marcadores genéticos e auto-imunes do diabetes melito tipo 1: da teoria para a prática. Arq Bras Endocrinol Metab [online]. 2008, vol.52, n.2, pp. 166-180. ISSN 0004-2730.  http://dx.doi.org/10.1590/S0004-27302008000200004.

    1. American Diabetes Association. Diagnosis and classification of diabetes. Diabetes Care. 2007;30 (Suppl 1):S42-7. [ Links ]

    2. Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab. 2007;3(1):36-45. [ Links ]

    3. Pozzilli P, Buzzetti R. A new expression of diabetes: double diabetes. Trends Endocrinol Metab. 2007;18(2):52-7. [ Links ]

    4. Jahromi MM, Eisenbarth GS. Cellular and molecular pathogenesis of type 1A diabetes. Cell Mol Life Sci. 2007;64(7-8):865-72. [ Links ]

    5. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Jaakko T. Incidence of childhood type 1 diabetes worldwide. Diabetes Care. 2000;23(10):1516-26. [ Links ]

    6. Eisenbarth GS, Lafferty K. Type 1 diabetes: cellular, molecular and clinical immunology. Disponível em: http://www.uchsc.edu/misc/diabetes/books.html< [ Links ]

    7. Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes. 2005;54 Suppl 2:S52-61. [ Links ]

    8. Kantárová D, Buc M. Genetic susceptibility to type 1 diabetes mellitus in humans. Physiol Res. 2007;56(3):255-66. [ Links ]

    9. Alizadeh BZ, Koeleman BP. Genetic polymorphisms in susceptibility to type 1 diabetes. Clin Chim Acta. 2008;387(1-2):9-17. [ Links ]

    10. Kelly MA, Rayner ML, Mijovic CH, Barnett AH. Molecular aspects of type 1 diabetes. Mol Pathol. 2003;56:1-10. [ Links ]

    11. Park Y. Functional evaluation of the type 1 diabetes (T1D) susceptibility candidate genes. Diabetes Res Clin Pract. 2007;77 (Suppl 1):S110-5. [ Links ]

    12. Barker JM. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab. 2006;91(4):1210-7. [ Links ]

    13. Reveille JD. The genetic basis of autoantibody production. Autoimmun Rev. 2006;5(6):389-98. [ Links ]

    14. Kawabata Y, Ikegami H, Kawaguchi Y, Fujisawa T, Shintani M, Ono M, et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and DQ haplotypes to susceptibility to type 1 diabetes. Diabetes. 2002;51:545-51. [ Links ]

    15. Davini E, Silva MER, Alves LI, Correia MRS, Fukui RT, Latrônico AC, et al. O genótipo I/I do locus VNTR do gene da insulina confere risco independente para diabetes mellitus tipo 1 nos pacientes sem os genótipos DRB1 e DQB1 de susceptibilidade. Arq Bras Endocrinol Metab. 2005;49 (Suppl 2):S876. [ Links ]

    16. Alves C, Meyer I, Vieira N, Toralles MBP, LeMaire D. Distribuição e freqüência de alelos e haplotipos HLA em brasileiros com diabetes melito tipo 1. Arq Bras Endocrinol Metab. 2006;50(3):436-44. [ Links ]

    17. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007;450 (7171):887-92. [ Links ]

    18. Törn C, Gupta M, Nikitina Zake L, Sanjeevi CB, Landin-Olsson M. Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults. Hum Immunol. 2003;64(9):902-9. [ Links ]

    19. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984;33:176-83. [ Links ]

    20. Undlien DE, Hamaguchi K, Kimura A, Tuomilehto-Wolf E, Swai AB, McLarty DG, et al. IDDM susceptibility associated with polymorphisms in the insulin gene region. A study of blacks, caucasians and orientals. Diabetologia. 1994;37:745-9. [ Links ]

    21. Hauache OM, Reis AF, Oliveira CS, Vieira JG, Sjoroos M, Ilonen J. Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-D-DQ, INS and CTLA-4 genes. Dis Markers. 2005;2:139-45. [ Links ]

    22. Hanukoglu A, Mizrachi A, Dalal I, Admoni O, Rakover Y, Bistritzer Z, et al. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care. 2003;26:1235-40. [ Links ]

    23. Ikegami H, Awata T, Kawasaki E, Kobayashi T, Maruyama T, Nakanish K, et al. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J Clin Endocrinol Metab. 2006;91(3):1087-92. [ Links ]

    24. Redondo MJ, Eisenbarth GS. Genetic control of autoimmunity in type 1 diabetes and associated disorders. Diabetologia. 2002;45:605-22. [ Links ]

    25. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 2003;423(6939):506-11. [ Links ]

    26. Gamberini M, Correia MRS, Davini E, Alves L, Mainardi-Novo DTO, Miura I, et al. Associação do polimorfismo + 49 A/G no exon 1 do gene CTLA-4 com diabetes melito tipo 1 e suas apresentações clínicas. Arq Bras Endocrinol Metab. 2006;50:S180. [ Links ]

    27. Bottini N, Muscumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M, et al. A functional variant of lymphoid tyrosine phosphatasis associated with type I diabetes. Nat Genet. 2004;36:337-8. [ Links ]

    28. Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005;76(4):561-71. [ Links ]

    29. Chelala C, Duchatelet S, Joffret ML, Bergholdt R, Dubois-Laforgue D, Ghandil P, et al. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes. 2007;56(2):522-6. [ Links ]

    30. Gamberini M, Crisostomo LG, Mainardi-Novo DT, Longhi MT, Davini E, Alves LI, et al. Genetic Association between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) with type 1 diabetes in caucasians. Program of the 89th Annual Meeting of the Endocrine Society, Toronto, CA, 2007, poster session. [ Links ]

    31. Oliveira CS, Hauache OM, Vieira JG, Maciel RM, Sjoroos M, Canani LH, et al. The ala45Thr polymorphism of NEUROD1 is associated with type 1 diabetes in Brazilian women. Diabetes Metab. 2005;31:599-602. [ Links ]

    32. Kavvoura FK, Ioannidis JP. Ala45Thr polymorphism of the NEUROD1 gene and diabetessusceptibility: a meta-analysis. Hum Genet. 2005;116:192-9. [ Links ]

    33. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of art. Trends Endocrinol Metab. 2005;16:261-6. [ Links ]

    34. Turpeinen H, Hermann R, Vaara S, Laine A, Simell O, Knip M, et al. Vitamin D receptor polymorphisms: no association with type 1 diabetes in the finnish population. Eur J Endocrinol. 2003;149:591-6. [ Links ]

    35. Guo S, Magnuson VL, Schiller JJ, Wang X, Ghosh S. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE Review of Genetic Association Studies. Am J Epidemiol. 2006;164:711-24. [ Links ]

    36. Mory DB, Rocco ER, Miranda WL, Kasamatsu T, Crispim F, Dib SA. Diferenças na relação dos polimorfismos do gene do receptor da vitamina D e a secreção de insulina nos indivíduos com diabetes melito tipo 1. Arq Bras Endocrinol Metab. 2007;51 (Supll 1):S498. [ Links ]

    37. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet. 2002;115:18-29. [ Links ]

    38. Achenbach P, Bonifacio E, Koczwara K, Ziegler AG. Natural history of type 1 diabetes. Diabetes. 2005;54 (Suppl 2):S25-31. [ Links ]

    39. Vandewalle CL, Falorni A, Svanholm S, Lernmark A, Pipeleers DG, Gorus FK. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry. J Clin Endocrinol Metab. 1995;80(3):846-51. [ Links ]

    40. Kasse CA, Miranda WL, Callari LEP, Sá JR, Dib AS. Auto-anticorpos antiilhota em diabéticos tipo 1 de diagnóstico recente e parentes de primeiro grau brasileiros. Arq Bras Endocrinol Metab. 1998;42(1):45-52. [ Links ]

    41. Silva MER, Fukui RT, Correia MRS, Ursich MJM, Nasser M, Rocha DM, et al. Anticorpos antiilhotas de Langerhans (ICA) em pacientes com diabetes mellitus (DM) com ínicio na idade adulta. Arq Bras Endocrinol Metab. 1993;37:103. [ Links ]

    42. Rosário PW, Reis JS, Fagundes TA, Calsolari MR, Amim R, Silva SC, et al. Latent autoimmune diabetes in adults (LADA): usefulness of anti-GAD antibody titers and benefit of early insulinization. Arq Bras Endocrinol Metabol. 2007;51(1):52-8. [ Links ]

    43. Mantovani RM, Mantovani LM, Dias VM. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus: prevalence and risk factors. J Pediatr Endocrinol Metab. 2007;20(6):669-75. [ Links ]

    44. Tanure MG, Silva IN, Bahia M, Penna FJ. Prevalence of celiac disease in Brazilian children with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr. 2006;42(2):155-9. [ Links ]

    45. Simmons JH, Klingensmith GJ, McFann K, Rewers M, Taylor J, Emery LM, et al. Impact of celiac autoimmunity on children with type 1 diabetes. J Pediatr. 2007;150(5):461-6. [ Links ]

    46. Mainardi-Novo DTO, Gamberini M, Longhi MT, Alves LI, Queiroz MS, Fukui RT, et al. Non-islet autoantibodies (non-isletAAb): prevalence and association with PTPN22 1858T in Brazilian Type I Diabetes Mellitus (DMI) Patients. Arq Bras Endocrinol Metabol. 2007;Supll 1:S103. [ Links ]

    47. Karges B, Muche R, Knerr I, Ertelt W, Wiesel T, Hub R, et al. Levothyroxine in euthyroid autoimmune thyroiditis and type 1 diabetes: a randomized, controlled trial. J Clin Endocrinol Metab. 2007;92(5):1647-52< [ Links ]